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Catalase (CAT) is part of the enzymatic defense system against reactive oxygen species (ROS), known 
to be involved in the pathogenesis of asbestosis. This study investigates whether CAT -262 C>T genetic 
polymorphism influences the risk of asbestosis in workers occupationally exposed to asbestos.
The nested case-control study included 262 cases with asbestosis and 265 controls with no asbestos-
related disease. Data on cumulative asbestos exposure and smoking were available. A real-time PCR assay 
was introduced for genotyping CAT -262 C>T promoter polymorphism.
A slightly elevated risk of asbestosis was observed in subjects with the CAT -262 TT genotype compared to 
others (OR=1.36, CI 0.70-2.62). This risk did not change substantially after adjustment by sex, age, and 
smoking, but the involvement of cumulative asbestos exposure changed the OR to 1.91 (CI 0.93-3.91).
These findings indicate that the CAT -262 TT genotype may be slightly associated with an increased risk 
of asbestosis. No synergistic effect was found between cumulative asbestos exposure and the CAT -262
TT genotype, but cumulative asbestos exposure acted as a confounder. These results are an important 
contribution to understanding the interactions between genetic and environmental factors that may modify 
the risk of asbestosis.
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Asbestosis is one of the most frequent diseases 
associated with asbestos exposure (1-3). The causal 
relationship between asbestos exposure and asbestosis 
has been proven in numerous epidemiological studies 
(4-7), but little is still known about the genetic factors 
that may influence individual susceptibility to this 
disease (8-10).
The pathogenesis of asbestosis is still poorly 
understood. Studies on animal models and cell 
cultures indicate that asbestos fibres generate reactive 
oxygen and nitric species (ROS and RNS) (3, 11-13). 
Asbestos may stimulate the production of ROS in 
two different ways. The first mechanism is due to 
the participation of redox-active iron in asbestos that 
catalyses the formation of hydroxyl radicals (OH˙), 
whereas the second mechanism is characterised by 
production of ROS by alveolar macrophages during 
the phagocytosis of asbestos fibres (14-16).
ROS generated by asbestos have been shown to be 
important signals for the induction of transcription and 
the production of inflammatory and fibrotic cytokines, 
oncogenes, and factors causing disregulation of 
growth control (13, 17). The most important ROS 
involved in the pathogenesis of asbestos-related lung 
diseases are superoxide anion (O2˙
-), hydroxyl radical 
(OH˙), and hydrogen peroxide (H2O2) (11, 18-20).
Oxidative stress can cause damage to cellular 
macromolecules; however, antioxidant defense 
enzymes that neutralize ROS are normally present 
in the cells and act as protectors. Catalase is an 
endogenous antioxidant enzyme that catalyses the 
reduction of H2O2 to water (H2O) and oxygen (O2),
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and therefore plays a major role in controlling H2O2
concentrations in human cells (21-23). Together with 
other antioxidant enzymes, it plays an important role in 
the primary defense against oxidative stress (21-23).
The results of several studies suggest that 
reduction in catalase activity may play an important 
role in the host response to oxidative stress, and could 
be associated with increased risk of certain diseases 
(23-26).
The human gene coding for catalase is located on 
chromosome 11p13 and consists of 13 exons (27). 
Several rare polymorphisms have been reported in 
the catalase gene (22). The most common single 
nucleotide polymorphism (SNP) in the promoter 
region of the catalase gene (CAT) consists of a 
cytosine (C) to thymine (T) substitution at position -
262 in the promoter region (CAT -262 C>T) (22). The 
association between CAT -262 C>T polymorphism 
and catalase activity or catalase levels has been 
investigated in several studies (22, 23, 28). Forsberg 
et al. found significantly higher catalase levels in 
individuals carrying the -262 T allele in comparison 
to individuals homozygous for the C allele (22). In 
contrast, in a study by Nadif et al., CAT -262 C>T 
polymorphism was significantly associated with 
erythrocyte catalase activity: the lowest was found in 
subjects with the TT genotype, an intermediate level 
in individuals with the CT genotype, and the highest in 
those with the CC genotype (28). Similar results were 
obtained in a cross-sectional study by Ahn et al., who 
found a dose-response reduction in catalase activity, 
with the highest geometric mean in individuals with 
the CAT -262 CC genotype, intermediate for those 
with the CT genotype, and the lowest for those with 
the TT genotype (23). Bastaki et al. also observed 
lower average catalase activity in subjects with the 
CAT -262 TT genotype compared to those with the 
CC genotype (29).
Recent studies indicate that genetic polymorphisms 
play an important role in susceptibility to the 
development of asbestosis (7, 9-10, 30-31). To our 
knowledge, the association between asbestosis and 
CAT -262 C>T polymorphism has not been studied 
so far.
To thoroughly investigate the interactions between 
genetic and environmental factors that could influence 
the risk of asbestosis, we designed a series of studies 
focusing on the most common polymorphisms 
of metabolic enzymes involved in the antioxidant 
response and xenobiotic detoxification in a large 
cohort of workers occupationally exposed to asbestos 
from a small geographic area with an ethnically 
homogenous population (32).
This study investigated the influence CAT -262 
C>T polymorphism on the risk of asbestosis in 
workers occupationally exposed to asbestos.
SUBJECTS AND METHODS
The study subjects were recruited from a cohort 
of 2,080 workers occupationally exposed to asbestos 
who were presented at the Board for the Recognition 
of Occupational Asbestos Diseases from 1 January 
1998 to 31 December 2003. From this cohort, 356 
cases diagnosed with asbestosis as an occupational 
disease and 356 controls with no asbestos-related 
disease were selected for a nested case-control study. 
The controls were matched to the cases by age and 
sex. However, 52 cases and 53 controls refused to take 
part in the study, 40 cases and 29 controls died in the 
period between the recognition of the occupational 
disease and the start of the study, and two cases and 
nine controls developed a malignant disease during 
the same period. Consequently, the final number 
of cases included in the study was 262 and that of 
controls 265.
All study cases and controls were employed 
at the Slovenian asbestos cement manufacturing 
plant Salonit Anhovo, where there were three major 
production processes: cement production, production 
of asbestos-cement pipes, and production of 
corrugated sheets (33).
Smoking data were obtained for each case 
and control at the interview using a standardised 
questionnaire (33, 34).
For each subject, data on cumulative asbestos 
exposure were available from the previous study 
(33).
The diagnosis of asbestosis or “no asbestos-
related disease” for each case and control was 
verified by experts from the Board for Recognition 
of Occupational Asbestos Diseases according to 
the Helsinki Criteria for Diagnosis and Attribution of 
Asbestos Diseases (35) and the American Thoracic 
Society proposal (36). Two experts teams from the 
Clinical Institute of Occupational Medicine in Ljubljana 
participated, each consisting of an occupational 
physician, a radiologist, and a pulmonologist.
For genotyping, capillary blood samples from the 
fingertips of all cases and controls were collected on 
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FTA Mini Cards (Whatmann Bioscience). Genomic 
DNA was extracted from the FTA cards using Blood 
Prep chemistry on the ABI PRISM™ 6100 Nucleic Acid 
PrepStation (Applied Biosystems, Foster City, CA) and 
stored at -20 °C until genotyping.
A custom TaqMan SNP genotyping assay (ABI, 
Foster City, CA) was used to determine CAT -262 C>T 
polymorphism. Primer and probe sets were designed 
as follows: -262 F: 5’GCCTGAAGGATGCTGATAAC
CG ’, -262 R: 5’CAATTGGAGAGCCTCGCC ’, -262 
C probe FAM-CCGGGATAGCCGAA, and -262 T 
probe VIC-CCCGGAATAGCCGAA. Real-time PCR 
was performed under universal conditions on ABI 
7900HT in a 5 µL reaction mix containing 0.125 µL 
of TaqMan SNP genotyping assay (ABI, Foster City, 
CA), 2.5 µL of TaqMan Universal PCR Master Mix (ABI, 
Foster City, CA), and 120 ng of DNA. Genotyping 
was randomly repeated in 20 % of samples to check 
for typing reliability. TaqMan SNP genotyping assays 
were validated on 100 samples genotyped using 
the PCR-RFLP method. To determine CAT -262 
C>T polymorphism, the region encompassing the 
polymorphic site was amplified and PCR products 
were digested with SmaI (New England Biolabs) as 
previously described (22).
Standard descriptive statistics were used. The 
differences in the means of variables between cases 
and controls were analysed using the t-test. A χ2
test was used to determine whether the observed 
differences in proportions between the study groups 
were statistically significant. The odds ratios (OR) and 
corresponding 95 % confidence intervals (CI) were 
calculated first using univariate logistic regression, 
followed by multivariate logistic regression modelling 
to assess the causal relationship between asbestosis, 
cumulative asbestos exposure, genotypes, and 
confounders. A possible synergistic effect was 
calculated between asbestos exposure and genotypes 
using dummy variables.
The study was approved by the Slovenian Ethics 
Committee for Research in Medicine and was carried 
out in line with the Helsinki Declaration.
RESULTS
The mean ages of cases and controls were 61 and 
57 years, respectively. No significant difference in sex 
distribution was found between cases and controls. 
No difference was observed with regard to smoking 
(Table 1) (7, 31).
The mean cumulative asbestos exposure was 
37.67 fibres/cm³-years (SD=86.43) in cases and 
11.23 fibres/cm³-years (SD=23.47) in controls. The 
difference in cumulative asbestos exposure between 
the cases and controls was statistically significant 
(t=4.78, p=0.000) (7, 31).
All cases and controls were genotyped for CAT -
262 C>T gene polymorphism. However, amplification 
was not successful in six cases and three controls. The 
CAT -262 TT genotype was found in 22 cases and 
17 controls, the CT genotype in 107 cases and 105 
controls, and the CC genotype in 127 cases and 140 
controls. When combining genotypes, there was no 








Mean ± SD 61 ± 9.40 57 ± SD 9.34 t=5.18 p=0.000
Sex
Male 186 183
Female 76 82 χ2=0.24 p=0.628
Smoking
Ever/never smokers 117/145 120/145 χ2=0.01 p=0.919
Average years
Mean ± SD
25.92 ± 13.37 22.90 ± 12.90 t=1.77 p=0.078
Average pack-years
Mean ± SD
21.92 ± 15.95 20.99 ± 16.37 t=0.44 p=0.659
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statistically significant difference in the frequency of 
the TT genotype versus the frequency of the CT and 
CC genotypes between cases and controls (χ2=0.82,
p=0.364) (Table 2).
Using logistic regression analysis, a positive 
association was found between asbestosis and 
cumulative asbestos exposure (OR=3.21, CI 2.43-
4.23). On the other hand, a lack of association was 
observed between asbestosis and smoking (ever/
never) (OR=0.98, CI 0.69-1.39). The OR of asbestosis 
was 1.27 (CI 0.64-2.53) for the CAT -262 TT versus 
CT genotype, 1.43 (CI 0.73-2.81) for the TT versus CC 
genotype, and 1.12 (CI 0.78-1.61) for the CT versus 
CC genotype. A slightly elevated OR of asbestosis was 
found for the CAT -262 TT genotype compared to the 
CT and CC genotypes (OR=1.36, CI 0.70-2.62) (Table 
3). The risk of asbestosis for the TT genotype did not 
change substantially after adjustment for sex, age, 
and smoking (Table 3). However, the involvement of 
cumulative asbestos exposure changed the OR from 
1.36 (CI 0.70-2.62) to 1.91 (CI 0.93-3.91) (Table 3), 
suggesting a confounding effect. In a subsequent 
analysis, a dummy variable was created by multiplying 
the TT genotype and cumulative asbestos exposure 
and included into logistic regression analysis together 
with the TT genotype and cumulative asbestos 
exposure, yielding an OR of 1.76 and p value of 0.369, 
showing no synergistic effect.
DISCUSSION
Interest in investigating the influence of both 
genetic and environmental factors on the development 
of diseases has recently been increasing (37-39). 
Among occupational diseases, asbestosis is one of 
the most frequently studied. Several studies have 
investigated the influence of genetic polymorphisms 
of metabolic enzymes on the risk of asbestosis, 
mostly focusing on the polymorphisms of glutathione 
S-transferases (GSTs) M1, T1, P1 (GSTM1, GSTT1 
and GSTP1), and manganese superoxide dismutase 
(MnSOD) (7-10, 30-31, 40). This study investigates 
the association between asbestosis and CAT -262 
C>T polymorphism. To our knowledge, this is the first 
attempt to assess the relationship between asbestosis 
and genetic polymorphism of catalase, which is known 
to be one of the major enzymes involved in the primary 
defence against oxidative stress.
This study observes a slightly elevated risk of 
asbestosis for the CAT -262 TT genotype versus the 
CT and CC genotypes. The results could be explained 
as biologically plausible, especially considering the 
findings of more recent studies, which showed lower 
catalase activity in subjects with the TT genotype 
compared to those with the CT and CC genotypes 
(23, 28-29). Because catalase plays an integral role 
in the primary defence against ROS, which are known 
to be included in the pathogenesis of asbestosis (11-
13), lower catalase activity in individuals with the CAT
-262 TT genotype could explain our findings of a likely 
increased risk of asbestosis in individuals carrying this 
genotype. One of the possible explanations why the 
risk was only slightly elevated may be that not only 
catalase but also other enzymes such as glutathione 
peroxidase (GPX) are involved in detoxification of 
H2O2, which is one of the ROS generated by asbestos 
fibres.
A dummy variable was used to test the possible 
synergistic effect between CAT genotypes and 
cumulative asbestos exposure. No such effect was 
observed. However, cumulative asbestos exposure 
was a confounder.
The results of this study must be considered 
in the context of observations by previous studies 
investigating the influence of genetic polymorphisms 
Table 2 Frequencies of CAT genotypes in cases and controls
Cases (N=256) Controls (N=262)
CAT genotype n % n % χ2 p value
TT 22 8.6 17 6.5
CT 107 41.8 105 40.1 0.47* 0.495
CC 127 49.6 140 53.4 1.07** 0.302
CT + CC 234 91.4 245 93.5 0.82*** 0.364
*χ2 calculated for TT vs. CT
**χ2 calculated for TT vs. CC
***χ2 calculated for TT vs. CT + CC
Franko A, et al. ASBESTOSIS AND CATALASE POLYMORPHISM
Arh Hig Rada Toksikol 2008;59:233-240
237
of certain other major enzymes involved in the 
detoxification of xenobiotics and inactivation of ROS 
and RNS on the risk of asbestosis (7-10, 30-31, 40-41). 
Important findings of our previous studies show that 
the GSTT1-null genotype, which results in the absence 
of an active enzyme, as well as the GSTP1 genotype 
coding for an enzyme with high conjugation capacity, 
were associated with an increased risk of asbestosis (7, 
31). In line with these reports, the results of this study, 
although statistically insignificant, could support the 
hypothesis that genetic polymorphisms of metabolic 
enzymes play an important role in the development 
of asbestosis. For this reason, we understand the 
findings of this study to be an important contribution 
to studying the influence of genetic factors on the risk 
of asbestosis and to new knowledge in investigating 
the role of CAT polymorphism in asbestosis, which has 
not been studied so far. The authors are aware that 
there may be a combined effect of all of the above 
mentioned polymorphisms. The relationship between 
them, which has yet to be proven, could be synergistic, 
additive, or independent.
All of the subjects included in this study were 
recruited in a small geographic area with an ethnically 
homogenous population, and no bias was introduced 
by genetic heterogeneity (32). Although approximately 
26 % of the cases and controls were excluded from the 
study because they died, developed cancer, or did not 
wish to participate, there were no differences in the 
cumulative asbestos exposure or diagnosis of cancer 
between the participants and the excluded group.
In conclusion, our results suggest that the CAT -
262 TT genotype may be associated with an increased 
risk of asbestosis. To clarify this finding, further studies 
are needed that include a larger number of subjects 
and that also investigate the CAT genotype-phenotype 
relationship.
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Izvle~ek
AZBESTOZA IN POLIMORFIZEM GENA ZA KATALAZO
Katalaza (CAT) je del encimskega obrambnega sistema proti reaktivnim kisikovim spojinam (ROS), za katere 
je znano, da so vpletene v patogenezo azbestoze. V raziskavi preu~ujemo, ali genetski polimorfizem CAT
-262 C>T vpliva na tveganje za nastanek azbestoze pri delavcih, ki so bili poklicno izpostavljeni azbestu.
Ugnezdena {tudija primerov s kontrolami je vklju~evala 262 primerov z azbestozo in 265 kontrol, ki niso 
imeli nobene bolezni, povezane z izpostavljenostjo azbestu. Na razpolago so bili podatki o celokupni 
izpostavljenosti azbestu in kajenju. Za genotipizacijo promotorskega polimorfizma CAT -262 C>T smo 
uporabili PCR v realnem ~asu.
Rahlo povi{ano tveganje za azbestozo smo opazili pri osebah z genotipom CAT -262 TT (RO=1,36, IZ 
0,70-2,62). Opisano tveganje se ni bistveno spremenilo po prilagoditvi po spolu, starosti in kajenju, pa~ 
pa se je razmerje obetov zvi{alo po uvedbi celokupne izpostavljenosti azbestu na 1,91 (IZ 0,93-3,91).
Rezultati ka`ejo, da genotip CAT -262 TT lahko povezujemo z rahlo pove~anim tveganjem za razvoj 
azbestoze. Sinergisti~nega u~inka med celokupno izpostavljenostjo azbestu in genotipom CAT -262 
TT nismo opazili, celokupna izpostavljenost azbestu pa je delovala kot mote~a spremenljivka. Rezultati 
predstavljajo pomemben prispevek k razumevanju sovpliva genetskih in okoljskih dejavnikov, ki bi lahko 
spremenili tveganje za nastanek azbestoze.
KLJU^NE BESEDE: izpostavljenost azbestu, PCR v realnem ~asu, vzro~na povezava, ugnezdena 
{tudija primerov s kontrolami 
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